Related references
Note: Only part of the references are listed.An electrochemical immunosensor for digoxin using core-shell gold coated magnetic nanoparticles as labels
Anita Ahmadi et al.
MOLECULAR BIOLOGY REPORTS (2014)
Curcumin and Silibinin Inhibit Telomerase Expression in T47D Human Breast Cancer Cells
Marzieh Nasiri et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
PAMAM Dendrimers Augment Inhibitory Effects of Curcumin on Cancer Cell Proliferation: Possible Inhibition of Telomerase
Mahdie Mollazade et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Inhibitory Effects of β-Cyclodextrin-Helenalin Complexes on H-TERT Gene Expression in the T47D Breast Cancer Cell Line - Results of Real Time Quantitative PCR
Samaneh Ghasemali et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Inhibition of Leptin and Leptin Receptor Gene Expression by Silibinin-Curcumin Combination
Kazem Nejati-Koshki et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Blastic Leukaemias (AML): A Biologist's View
Julio Roberto Caceres-Cortes
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
On the selectivity and efficacy of defense peptides with respect to cancer cells
Frederick Harris et al.
MEDICINAL RESEARCH REVIEWS (2013)
Protein detection through different platforms of immuno-loop-mediated isothermal amplification
Mohammad Pourhassan-Moghaddam et al.
NANOSCALE RESEARCH LETTERS (2013)
Inhibition of leptin gene expression and secretion by silibinin: possible role of estrogen receptors
Kazem Nejati-Koshki et al.
CYTOTECHNOLOGY (2012)
Nanoimmunotherapy: application of nanotechnology for sustained and targeted delivery of antigens to dendritic cells
Zhiping Zhang et al.
NANOMEDICINE (2012)
Docetaxel and 5-fluorouracil induce human p53 tumor suppressor gene transcription via a short sequence at core promoter element
Jui-Chuan Chuang et al.
TOXICOLOGY IN VITRO (2012)
Synthesis, characterization and in vitro studies of doxorubicin-loaded magnetic nanoparticles grafted to smart copolymers on A549 lung cancer cell line
Abolfazl Akbarzadeh et al.
JOURNAL OF NANOBIOTECHNOLOGY (2012)
Catalytic ozone oxidation of benzene at low temperature over MnOx/Al-SBA-16 catalyst
Jong Hwa Park et al.
NANOSCALE RESEARCH LETTERS (2012)
Nuclear initiated NF-kappa B signaling: NEMO and ATM take center stage
Shigeki Miyamoto
CELL RESEARCH (2011)
Backbone Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt)
Yftah Tal-Gan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Targeting mTOR for the treatment of AML. New agents and new directions.
Jessica K. Altman et al.
ONCOTARGET (2011)
Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia
Sophie Park et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Signal transduction therapy of cancer
Alexander Levitzki et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Peptide Inhibitors Targeting Protein Kinases
Hagit Eldar-Finkelman et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Cell penetrating peptide inhibitors of Nuclear Factor-kappa B
J. S. Orange et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Multildrug resistance in acute myeloid leukemia: Potential new therapeutics
Jeffrey H. Weisburg
JOURNAL OF NUCLEAR MEDICINE (2008)
Deregulation of signaling pathways in acute myeloid leukemia
Claudia Scholl et al.
SEMINARS IN ONCOLOGY (2008)
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zhihong Zeng et al.
BLOOD (2007)
AKT crystal structure and AKT-specific inhibitors
CC Kumar et al.
ONCOGENE (2005)
Selective inhibition of NF-κB in dendritic cells by the NEMO-binding domain peptide blocks maturation and prevents T cell proliferation and polarization
SW Tas et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Constitutive NF-kappa B DNA-binding activity in AML is frequently mediated by a Ras/PI3-K/PKB-dependent pathway
KU Birkenkamp et al.
LEUKEMIA (2004)
NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells
M Bentires-Alj et al.
ONCOGENE (2003)
Share Paper
